Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Feb 21, 2019 6:45am
97 Views
Post# 29392269

RE:RE:RE:BlueMetal75 + BionicJoe?

RE:RE:RE:BlueMetal75 + BionicJoe?I've retired from this board folks. Don't give me a reason for returning.

BTW, for bencro, what goes around comes around. You've always worked hard to have other posters banned. Looks like you were not immune from it being done to you.

Floatinkentucky, you seem confused about the closing of the shelf prospectus. What you fail to disclose is the information was posted on Sedar by the Ontario Securities Commission. Don't you feel if it was as positive as you imply that the company would have issued a PR to reach a wider general audience than Sedar?

Good luck to all. You need to have the question of how the company will pay for the phase 2 trial solved if you hope to have a different class of investor looking seriously at the stock. As long as there is the potential of a large PP some investors might consider it prudent to wait on the sidelines in the hope of getting a better entry price.

Be careful and don't listen to the rumors.
Bullboard Posts